Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Disorders of the Nervous System

Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex

Tristan D. McClure-Begley, Irina Esterlis, Kathryn L. Stone, TuKiet T. Lam, Sharon R. Grady, Christopher M. Colangelo, Jon M. Lindstrom, Michael J. Marks and Marina R. Picciotto
eNeuro 3 August 2016, 3 (4) ENEURO.0166-16.2016; https://doi.org/10.1523/ENEURO.0166-16.2016
Tristan D. McClure-Begley
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80303
3Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado 80309
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tristan D. McClure-Begley
Irina Esterlis
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn L. Stone
4W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, Connecticut 06509
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TuKiet T. Lam
4W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, Connecticut 06509
5Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, Connecticut 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for TuKiet T. Lam
Sharon R. Grady
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Colangelo
4W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, Connecticut 06509
5Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, Connecticut 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher M. Colangelo
Jon M. Lindstrom
6Department of Neuroscience, Medical School of the University of Pennsylvania, Philadelphia, Pennsylvania 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Marks
2Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80303
7Department of Psychology and Neuroscience, University of Colorado, Boulder, Colorado 80309
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina R. Picciotto
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508
4W.M. Keck Biotechnology Resource Laboratory, Yale University School Medicine, New Haven, Connecticut 06509
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marina R. Picciotto
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Effects of nicotine use and mood disorder on total high-affinity [125I]-epibatidine binding in cell membranes from human temporal cortex samples. A, Nicotine use, determined by tissue cotinine content, has a significant effect on the number of total [125I]-epibatidine binding sites (two-way ANOVA with Holm–Sidak multiple comparisons: F(1,17) = 9.794, p = 0.007), while mood disorder does not have an appreciable effect on the expression of high-affinity nAChRs in the cortex (F(1,17) = 0.224, p = 0.673). B, β2*-nAChR capture was evaluated by [125I]-epibatidine binding following immunoprecipitation from human temporal cortex using mAb295-M270 Dynabeads. Error bars represent standard error of the mean.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    [125I]-epibatidine binding to α4β2*-nAChRs in human temporal cortex homogenates correlates well with β2-nAChR (A) and α4-nAChR (B) subunit abundance estimated by normalized unique peptide abundance determined by peptide LC-MS/MS.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Effects of long-term treatment with saline or 4 mg/kg/h nicotine treatment on captured [125I]-epibatidine binding sites from pooled cortex from wild-type (β2+/+, W), heterozygous (β2+/−, H), double-heterozygous (α4+/−β2+/−, DH), and knock-out (β2−/−, K) mice. Gene dose-dependent changes in receptor capture are apparent (two-way ANOVA; main effect, genotype: F(3,15) = 59.314, p < 0.0009), as is the upregulation produced by long-term nicotine exposure in all but the β2−/− genotype groups (main effect, nicotine: F(1,15) = 29.05, p < 0.0009). Error bars represent standard error of the mean.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    A, Representation of the log2-normalized fold change in β2*-nAChR-associated proteins in human temporal cortex relative to the non-nicotine, non-MD group average. The graph shows nAChR-associated proteins whose expression is significantly impacted by nicotine, MD, or an interaction, according to GLM. Group means above zero are upregulated by nicotine exposure, indicating that as nAChR levels increase, so do the levels of those proteins. Increases in excess of the log2 fold change for the α4- and β2-nAChR subunits indicate a superstoichiometric shift. B, Log2 protein abundance normalized to within-sample β2-nAChR protein content for five proteins that showed a significant shift with nicotine use. Normalization demonstrates the change in protein expression per molecule of the nAChR β2-subunit in human cortical samples. For these samples, LFQ proteomics allows the comparison of protein levels, even when the variation in total abundance across treatments is small. Normalization to an internal standard in each condition (β2-subunit levels) allows the measurement of more discrete changes than are apparent from fold change estimates.

Tables

  • Figures
    • View popup
    Table 1.

    Tabulation of all proteins identified from mAb295-immunoisolated β2*-nAChRs from human temporal cortex, indicating which proteins have been identified in mouse cortex or whole mouse brain (Iso, isoform of protein identified; GN, gene name)

    Accession_HUMANDescriptionMouse CtxMouse Brain
    1433E14-3-3 protein ε GN = YWHAEIsoIso
    1433G;1433F14-3-3 protein γ GN = YWHAGIsoIso
    1433S14-3-3 protein σ GN = SFNIsoIso
    1433Z14-3-3 protein ζ/δ GN = YWHAZIsoYes
    ACHA4;ACHA2;ACHA6Neuronal acetylcholine receptor subunit α4 GN = CHRNA4YesYes
    ACHB2Neuronal acetylcholine receptor subunit β2 GN = CHRNB2YesYes
    ACTB;ACTBM;POTEEActin, cytoplasmic 1 GN = ACTBYesIso
    ACTC;ACTAActin, α cardiac muscle 1 GN = ACTC1IsoYes
    ACTN1;ACTN3α-Actinin-1 GN = ACTN1NoYes
    ACTN2α-Actinin-2 GN = ACTN2NoYes
    ACTN4α-Actinin-4 GN = ACTN4NoIso
    ADDAα-Adducin GN = ADD1NoNo
    ADT1;ADT2;ADT4ADP/ATP translocase 1 GN = SLC25A4YesYes
    ALBUSerum albumin GN = ALBNoNo
    ANK2Ankyrin-2 GN = ANK2NoYes
    AP1B1AP-1 complex subunit β1 GN = AP1B1NoNo
    ARP2Actin-related protein 2 GN = ACTR2NoIso
    ARP3Actin-related protein 3 GN = ACTR3NoYes
    ARPC3Actin-related protein 2/3 complex subunit 3 GN = ARPC3NoIso
    ARPC4Actin-related protein 2/3 complex subunit 4 GN = ARPC4NoIso
    AT1A1;AT12ASodium/potassium-transporting ATPase subunit α1 GN = ATP1A1IsoIso
    AT1A2Sodium/potassium-transporting ATPase subunit α2 GN = ATP1A2IsoYes
    AT1A3;AT1A4;ATP4ASodium/potassium-transporting ATPase subunit α3 GN = ATP1A3YesYes
    AT1B1Sodium/potassium-transporting ATPase subunit β1 GN = ATP1B1YesYes
    AT2B2;AT2B1Plasma membrane calcium-transporting ATPase 2 GN = ATP2B2NoNo
    ATPAATP synthase subunit α, mito GN = ATP5A1YesYes
    ATPBATP synthase subunit β, mito GN = ATP5BYesYes
    BASP1Brain acid-soluble protein 1 GN = BASP1NoNo
    CALMCalmodulin GN = CALM1YesYes
    CANB1Calcineurin subunit B type 1 GN = PPP3R1NoNo
    CLH1Clathrin heavy chain 1 GN = CLTC SV = 5YesNo
    CNTN1Contactin-1 GN = CNTN1NoYes
    COX2Cytochrome c oxidase subunit 2 GN = MT-CO2NoYes
    COX41Cytochrome c oxidase subunit 4 isoform 1, mito GN = COX4I1NoYes
    COX6CCytochrome c oxidase subunit 6C GN = COX6CNoYes
    CX6B1Cytochrome c oxidase subunit 6B1 GN = COX6B1NoYes
    CX7A2Cytochrome c oxidase subunit 7A2, mito GN = COX7A2NoYes
    DREBDrebrin GN = DBN1NoYes
    DYN1Dynamin-1 GN = DNM1NoNo
    E41L3Band 4.1-like protein 3 GN = EPB41L3NoNo
    EAA1Excitatory amino acid transporter 1 GN = SLC1A3IsoIso
    EAA2Excitatory amino acid transporter 2 GN = SLC1A2YesYes
    EF1A1;EF1A2Elongation factor 1-α1 GN = EEF1A1NoNo
    FCGBPIgGFc-binding protein GN = FCGBPNoNo
    FRIHFerritin heavy chain GN = FTH1NoNo
    FRILFerritin light chain GN = FTLNoNo
    G3PGlyceraldehyde-3-phosphate dehydrogenase GN = GAPDHYesYes
    GBB1;GBB2;GBB3;GBB4Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit β1 GN = GNB1YesYes
    GELSGelsolin GN = GSNNoYes
    GFAPGlial fibrillary acidic protein GN = GFAPYesYes
    GNAO;GNA12Guanine nucleotide-binding protein G(o) subunit α GN = GNAO1YesYes
    GPM6ANeuronal membrane glycoprotein M6-a GN = GPM6ANoNo
    H13Histone H1.3 GN = HIST1H1DNoIso
    H2A1BHistone H2A type 1-B/E GN = HIST1H2ABNoYes
    H2B1M;H2B1AHistone H2B type 1-M GN = HIST1H2BMNoYes
    H4Histone H4 GN = HIST1H4ANoYes
    HBAHemoglobin subunit α GN = HBA1NoIso
    HBB;HBDHemoglobin subunit β GN = HBBNoYes
    HORNHornerin GN = HRNRNoNo
    HS12AHeat shock 70 kDa protein 12A GN = HSPA12ANoIso
    HS71LHeat shock 70 kDa protein 1-like GN = HSPA1LNoIso
    HSPB1Heat shock protein β1 GN = HSPB1NoIso
    IGHG4;IGHG2Ig γ-4 chain C region GN = IGHG4NoIso
    IGHMIg μ chain C region GN = IGHMNoYes
    IGKCIg κ chain C region GN = IGKCNoIso
    KCC2A;KCC2DCalcium/calmodulin-dependent protein kinase type II subunit α GN = CAMK2AYesYes
    KCC2B;KCC2GCalcium/calmodulin-dependent protein kinase type II subunit β GN = CAMKIIBYesYes
    MBPMyelin basic protein GN = MBPYesYes
    ML12A;MYL9Myosin regulatory light chain 12A GN = MYL12ANoIso
    MOGMyelin-oligodendrocyte glycoprotein GN = MOGNoNo
    MPCPPhosphate carrier protein, mito GN = SLC25A3YesYes
    MYH10Myosin-10 GN = MYH10YesYes
    MYH9;MYH11;MYH14Myosin-9 GN = MYH9IsoYes
    MYL6;MYL6BMyosin light polypeptide 6 GN = MYL6YesYes
    MYO5A;MYO5BUnconventional myosin-Va GN = MYO5ANoYes
    MYPRMyelin proteolipid protein GN = PLP1NoYes
    NDUA4Cytochrome c oxidase subunit NDUFA4 GN = NDUFA4YesIso
    NDUS3NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mito GN = NDUFS3YesYes
    NDUV2NADH dehydrogenase [ubiquinone] flavoprotein 2, mito GN = NDUFV2YesYes
    NFLNeurofilament light polypeptide GN = NEFLYesYes
    NFMNeurofilament medium polypeptide GN = NEFMYesYes
    NSFVesicle-fusing ATPase GN = NSFNoYes
    ODB2Lipoamide acyltransferase of branched-chain α-keto acid dehydrogenase mito GN = DBTNoYes
    ODO2Dihydrolipoyllysine-residue succinyltransferase 2-oxoglutarate dehydrogenase mito GN = DLSTYesYes
    QCR2Cytochrome b-c1 complex subunit 2, mito GN = UQCRC2NoYes
    RAB1ARas-related protein Rab-1A GN = RAB1AIsoYes
    RL40Ubiquitin-60S ribosomal protein L40 GN = UBA52NoNo
    RO52E3 ubiquitin-protein ligase TRIM21 GN = TRIM21NoNo
    S10A7;S1A7AProtein S100-A7 GN = S100A7NoNo
    S10A8Protein S100-A8 GN = S100A8NoNo
    S10A9Protein S100-A9 GN = S100A9NoNo
    SIR2NAD-dependent protein deacetylase sirtuin-2 GN = SIRT2NoNo
    SNP25Synaptosomal-associated protein 25 GN = SNAP25YesYes
    SPTB2;SPTB1Spectrin β chain, nonerythrocytic 1 GN = SPTBN1YesYes
    SPTN1Spectrin α chain, nonerythrocytic 1 GN = SPTAN1YesYes
    SPTN2Spectrin β chain, nonerythrocytic 2 GN = SPTBN2IsoIso
    SSBPSingle-stranded DNA-binding protein, mito GN = SSBP1NoNo
    STX1ASyntaxin-1A GN = STX1AIsoIso
    STX1B;STX2Syntaxin-1B GN = STX1BYesYes
    STXB1Syntaxin-binding protein 1 GN = STXBP1NoYes
    SV2ASynaptic vesicle glycoprotein 2A GN = SV2ANoNo
    SYT1Synaptotagmin-1 GN = SYT1YesYes
    TBA1A,C;TBA3C,E;TBA8Tubulin α1A chain GN = TUBA1AIsoYes
    TBA1BTubulin α1B chain GN = TUBA1BIsoIso
    TBA4A;TBA4B;TBAL3Tubulin α4A chain GN = TUBA4AYesYes
    TBB2A;TBB1;TBB2BTubulin β2A chain GN = TUBB2AYesYes
    TBB3Tubulin β3 chain GN = TUBB3YesYes
    TBB4A;TBB6,8;TBB8LTubulin β4A chain GN = TUBB4AYesYes
    TBB4BTubulin β4B chain GN = TUBB4BYesYes
    TBB5Tubulin β chain GN = TUBBYesYes
    THY1Thy-1 membrane glycoprotein GN = THY1YesNo
    TMOD2Tropomodulin-2 GN = TMOD2NoYes
    TPM4;TPM1Tropomyosin α4 chain GN = TPM4IsoNo
    VA0D1;VA0D2V-type proton ATPase subunit d 1 GN = ATP6V0D1YesIso
    VAMP3Vesicle-associated membrane protein 3 GN = VAMP3NoIso
    VATAV-type proton ATPase catalytic subunit A GN = ATP6V1AYesYes
    VISL1Visinin-like protein 1 GN = VSNL1NoNo
    VPP1V-type proton ATPase 116 kDa subunit a isoform 1 GN = ATP6V0A1 PE = 2YesIso
    • View popup
    Table 2.

    Statistical analyses indicating significance of variance with levels of the β2-nAChR subunit

    Accession_HUMANANOVA (p)Peptides
    ACTB;ACTBM;POTEE;POTEF;POTEI;POTEJ1.10E-1130
    S10A91.67E-115
    ODO22.50E-112
    ACTC;ACTA1.51E-101
    BASP12.15E-102
    ACTN21.03E-095
    KCC2A;KCC2D2.14E-0911
    TBA4A;TBA4B;TBAL32.40E-093
    TBA1A;TBA1C;TBA3C;TBA3E;TBA82.92E-092
    MYH9;MYH11;MYH143.28E-096
    S10A7;S1A7A3.97E-092
    AT1A1;AT12A6.35E-097
    AT1B19.37E-093
    TBA1B6.14E-082
    VAMP32.62E-071
    TBB4A;TBB6;TBB8;TBB8L3.00E-0710
    H2B1M;H2B1A3.68E-074
    RL408.67E-072
    MYH101.11E-0618
    FCGBP1.34E-0619
    ODB22.48E-065
    COX412.57E-062
    GELS3.76E-0610
    HS12A3.82E-064
    AT1A3;AT1A4;ATP4A4.09E-0619
    TBB2A;TBB1;TBB2B4.12E-0625
    ACTN1;ACTN31.03E-0519
    TBB51.04E-052
    ADT1;ADT2;ADT41.09E-053
    IGHG4;IGHG21.34E-053
    EF1A1;EF1A21.53E-052
    DREB2.67E-055
    COX23.01E-052
    CLH14.69E-052
    CNTN15.48E-051
    IGKC5.53E-051
    STX1B;STX26.30E-056
    H138.79E-051
    EAA21.11E-042
    CX7A21.19E-041
    ANK21.43E-043
    VISL11.84E-042
    MYO5A;MYO5B2.45E-048
    ML12A;MYL94.10E-044
    S10A84.70E-042
    ATPA5.39E-043
    ACTN45.80E-045
    GFAP6.13E-0416
    ARPC46.76E-042
    ACHB27.24E-0410
    ARPC31.22E-031
    CANB11.35E-031
    STXB11.55E-033
    TBB4B1.58E-031
    TBB31.73E-032
    MPCP2.04E-031
    1433Z2.60E-032
    H42.92E-033
    MYPR2.96E-035
    NDUS33.08E-031
    GPM6A3.13E-032
    E41L33.53E-031
    CALM3.66E-032
    H2A1B4.17E-031
    FRIH4.43E-033
    SPTN14.48E-0357
    GNAO;GNA124.51E-034
    ACHA4;ACHA2;ACHA65.52E-0323
    DYN15.67E-034
    ARP35.99E-032
    SIR26.01E-031
    HS71L7.68E-031
    ARP28.71E-034
    SPTB2;SPTB10.01300048
    QCR20.0193051
    SPTN20.0193793
    AP1B10.0239241
    VA0D1;VA0D20.0267614
    1433E0.0281731
    HBB;HBD0.0317134
    AT2B2;AT2B10.0330052
    HORN0.0374592
    VPP10.0476732
    MBP0.0535086
    1433G;1433F0.0667812
    TMOD20.0669061
    IGHM0.0679341
    SV2A0.0692901
    KCC2B;KCC2G0.0701102
    ATPB0.0745123
    RAB1A0.0765811
    FRIL0.0838361
    VATA0.0892881
    ADDA0.0933822
    AT1A20.1263313
    RO520.12654412
    EAA10.1311821
    1433S0.1493901
    STX1A0.1551904
    SNP250.1931397
    ALBU0.2498292
    HBA0.2548672
    SYT10.2572542
    G3P0.2633793
    MYL6;MYL6B0.3654165
    GBB1;GBB2;GBB3;GBB40.3782677
    TPM4;TPM10.4094693
    COX6C0.4563031
    NDUA40.5116532
    CX6B10.5807611
    SSBP0.6405672
    NSF0.6667538
    MOG0.7443182
    NFM0.7692242
    THY10.7786192
    NDUV20.8023231
    NFL0.8426945
    HSPB10.9413991
    • View popup
    Table 3.

    Proteins coimmunopurified with β2*-nAChRs from postmortem human temporal cortex with abundances that correlate significantly with the abundance of the β2 nAChR subunit

    AccessionDescriptionCorrelation (r)p Valuen
    ACHB2_HUMANNeuronal acetylcholine receptor subunit β21018
    ACHA4_HUMANNeuronal acetylcholine receptor subunit α40.972<0.000918
    AT1B1_HUMANSodium/potassium-transporting ATPase subunit β10.889<0.000918
    AT1A3_HUMANSodium/potassium-transporting ATPase subunit α30.888<0.000918
    SNP25_HUMANSynaptosomal-associated protein 250.88<0.000918
    STX1B_HUMANSyntaxin-1B0.874<0.000918
    AT1A1_HUMANSodium/potassium-transporting ATPase subunit α10.871<0.000918
    ANK2_HUMANAnkyrin-20.856<0.000918
    STX1A_HUMANSyntaxin-1A0.844<0.000918
    GPM6A_HUMANNeuronal membrane glycoprotein M6-a0.823<0.000918
    AT2B2_HUMANPlasma membrane calcium-transporting ATPase 20.781<0.000918
    GNAO_HUMANGuanine nucleotide-binding protein G(o) subunit α0.781<0.000918
    VPP1_HUMANV-type proton ATPase 116 kDa subunit a isoform 10.777<0.000918
    MYPR_HUMANMyelin proteolipid protein0.762<0.000918
    GBB1_HUMANGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit β10.7020.00118
    EAA2_HUMANExcitatory amino acid transporter 20.7010.00118
    VA0D1_HUMANV-type proton ATPase subunit d 10.6440.00418
    MYH9_HUMANMyosin-90.6310.00518
    AT1A2_HUMANSodium/potassium-transporting ATPase subunit α20.6090.00718
    TBB5_HUMANTubulin β chain0.5760.01218
    TBA1A_HUMANTubulin α1A chain0.560.01618
    1433Z_HUMAN14-3-3 protein zeta/delta0.5480.01918
    STXB1_HUMANSyntaxin-binding protein 10.5260.02518
    SYT1_HUMANSynaptotagmin-10.5230.02618
    CLH1_HUMANClathrin heavy chain 10.5150.04118
    TBA4A_HUMANTubulin α4A chain0.5140.02918
    S10A7_HUMANProtein S100-A70.5110.0318
    TBA1B_HUMANTubulin α1B chain0.5060.03218
    RO52_HUMANE3 ubiquitin-protein ligase TRIM210.4920.03818
    ODO2_HUMANDihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex0.4830.04218
    TBB4A_HUMANTubulin β4A chain0.4760.04618
    MYO5A_HUMANUnconventional myosin-Va0.4750.04618
    TPM4_HUMANTropomyosin α4 chain0.4730.04718
    • High correlation indicates the identified protein is either specifically interacting with the receptor at the time of tissue lysis or is part of a complex that stays intact following extraction in Triton X-100. The cluster of proteins with correlation coefficients <0.7 is evidence of significant enrichment of presynaptic components critical for neurotransmitter release and neuronal excitability.

    • View popup
    Table 4.

    Tabulation of all proteins identified in common between two biological replicates of eight-plex iTRAQ-labeled β2*-nAChRs immunoisolated with mAb295 from mouse cortex, indicating which proteins have been identified in human temporal cortex or whole mouse brain (Iso, isoform of protein identified; GN, gene name)

    Accession_MOUSEDescriptionHuman CtxMouse brain
    1433T14-3-3 protein theta GN = YwhaqIsoIso
    ACHA4Neuronal acetylcholine receptor subunit α4 GN = Chrna4YesYes
    ACHA5Neuronal acetylcholine receptor subunit α5 GN = Chrna5IsoIso
    ACHB2Neuronal acetylcholine receptor subunit β2 GN = Chrnb2YesYes
    ACPMAcyl carrier protein, mito GN = Ndufab1NoYes
    ACTG; ACTBActin, cytoplasmic 2 GN = Actg1; actin, cytoplasmic 1 GN = ActbIsoYes
    ADT1ADP/ATP translocase 1 GN = Slc25a4 SV = 4YesYes
    ADT2ADP/ATP translocase 2 GN = Slc25a5YesYes
    AINXα-Internexin GN = InaNoYes
    AT1A3Sodium/potassium-transporting ATPase subunit α3 GN = Atp1a3YesYes
    AT1B1Sodium/potassium-transporting ATPase subunit β1 GN = Atp1b1YesYes
    AT5F1ATP synthase subunit b, mito GN = Atp5f1IsoYes
    ATP5HATP synthase subunit d, mito GN = Atp5hIsoYes
    ATP5IATP synthase subunit e, mito GN = Atp5iIsoYes
    ATPAATP synthase subunit α, mito GN = Atp5a1YesYes
    ATPBATP synthase subunit β, mito GN = Atp5bYesYes
    ATPDATP synthase subunit delta, mito GN = Atp5dIsoYes
    C1QAComplement C1q subcomponent subunit A GN = C1qaNoNo
    CALMCalmodulin GN = Calm1YesYes
    CLH1Clathrin heavy chain 1 GN = CltcYesNo
    CMC1Calcium-binding mito carrier protein Aralar1 GN = Slc25a12NoYes
    CN372',3'-cyclic-nucleotide 3'-phosphodiesterase GN = CnpNoYes
    EAA2Excitatory amino acid transporter 2 GN = Slc1a2YesYes
    G3PGlyceraldehyde-3-phosphate dehydrogenase GN = GapdhYesYes
    GBB1Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit β1 GN = Gnb1YesYes
    GFAPGlial fibrillary acidic protein GN = Gfap SV = 4YesYes
    GLNAGlutamine synthetase GN = Glul SV = 6NoYes
    GNAOGuanine nucleotide-binding protein G(o) subunit α GN = Gnao1YesYes
    KCC2ACalcium/calmodulin-dependent protein kinase type II subunit α GN = CaMKIIaYesYes
    KCC2BCalcium/calmodulin-dependent protein kinase type II subunit β GN = CaMKIIbYesYes
    M2OMMito 2-oxoglutarate/malate carrier protein GN = Slc25a11NoYes
    MBPMyelin basic protein GN = MbpYesYes
    MPCPPhosphate carrier protein, mito GN = Slc25a3YesYes
    MYH10Myosin-10 GN = Myh10YesYes
    MYL6Myosin light polypeptide 6 GN = Myl6YesYes
    NDUA2NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 2 GN = Ndufa2IsoYes
    NDUA4NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 4 GN = Ndufa4YesIso
    NDUA5NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 5 GN = Ndufa5IsoYes
    NDUA6NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 6 GN = Ndufa6IsoYes
    NDUA7NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 7 GN = Ndufa7IsoYes
    NDUA9NADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 9, mito GN = Ndufa9IsoYes
    NDUAANADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 10, mito GN = Ndufa10IsoYes
    NDUACNADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 12 GN = Ndufa12IsoYes
    NDUADNADH dehydrogenase [ubiquinone] 1 α subcomplex subunit 13 GN = Ndufa13IsoYes
    NDUB3NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 3 GN = Ndufb3IsoYes
    NDUB4NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 4 GN = Ndufb4IsoYes
    NDUB5NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 5, mito GN = Ndufb5IsoYes
    NDUB6NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 6 GN = Ndufb6IsoYes
    NDUB7NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 7 GN = Ndufb7IsoYes
    NDUB8NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 8, mito GN = Ndufb8IsoYes
    NDUB9NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 9 GN = Ndufb9IsoYes
    NDUC2NADH dehydrogenase [ubiquinone] 1 subunit C2 GN = Ndufc2IsoYes
    NDUS1NADH-ubiquinone oxidoreductase 75 kDa subunit, mito GN = Ndufs1IsoYes
    NDUS2NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mito GN = Ndufs2IsoYes
    NDUS3NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mito GN = Ndufs3YesYes
    NDUS4NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mito GN = Ndufs4IsoYes
    NDUS5NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 GN = Ndufs5IsoYes
    NDUS6NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mito GN = Ndufs6IsoYes
    NDUS7NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mito GN = Ndufs7IsoYes
    NDUS8NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mito GN = Ndufs8IsoYes
    NDUV1NADH dehydrogenase [ubiquinone] flavoprotein 1, mito GN = Ndufv1IsoYes
    NDUV2NADH dehydrogenase [ubiquinone] flavoprotein 2, mito GN = Ndufv2YesYes
    NESTNestin GN = NesNoNo
    NFHNeurofilament heavy polypeptide GN = NefhIsoIso
    NFLNeurofilament light polypeptide GN = Nefl SV = 5YesYes
    NFMNeurofilament medium polypeptide GN = Nefm SV = 4YesYes
    OCAD2OCIA domain-containing protein 2 GN = Ociad2NoYes
    ODO2Dihydrolipoyl-lysine residue succinyltransferas 2-oxoglutarate dehydrogenase complex, mito GN = DlstYesYes
    ODPAPyruvate dehydrogenase E1 component subunit α, somatic form, mito GN = Pdha1NoYes
    ODPBPyruvate dehydrogenase E1 component subunit β, mito GN = PdhbNoYes
    PHBProhibitin GN = PhbNoYes
    PHB2Prohibitin-2 GN = Phb2NoYes
    RAB3ARas-related protein Rab-3A GN = Rab3aIsoYes
    SFXN3Sideroflexin-3 GN = Sfxn3NoYes
    SNP25Synaptosomal-associated protein 25 GN = Snap25YesYes
    SPTB2Spectrin β chain, nonerythrocytic 1 GN = Sptbn1YesYes
    SPTN1Spectrin α chain, nonerythrocytic 1 GN = Sptan1 SV = 4YesYes
    STX1BSyntaxin-1B GN = Stx1bYesYes
    SYPHSynaptophysin GN = SypNoNo
    SYT1Synaptotagmin-1 GN = Syt1YesYes
    TBA4ATubulin α4A chain GN = Tuba4aYesYes
    TBB2ATubulin β2A chain GN = Tubb2aYesYes
    TBB3Tubulin β3 chain GN = Tubb3YesYes
    TBB4ATubulin β4A chain GN = Tubb4aYesYes
    TBB4BTubulin β4B chain GN = Tubb4bYesYes
    TBB5Tubulin β5 chain GN = Tubb5YesYes
    THY1Thy-1 membrane glycoprotein GN = Thy1YesNo
    TPM3Tropomyosin α3 chain GN = Tpm3IsoNo
    VA0D1V-type proton ATPase subunit d 1 GN = Atp6v0d1YesIso
    VATAV-type proton ATPase catalytic subunit A GN = Atp6v1aYesYes
    VDAC1Voltage-dependent anion-selective channel protein 1 GN = Vdac1NoYes
    VDAC2Voltage-dependent anion-selective channel protein 2 GN = Vdac2NoYes
    VIMEVimentin GN = VimNoYes
    VPP1V-type proton ATPase 116 kDa subunit a isoform 1 GN = Atp6v0a1YesIso
    • View popup
    Table 5.

    β2*-nAChR interacting proteins identified by iTRAQ analysis of receptors isolated from transgenic mouse cortex receiving long-term treatment with nicotine and not receiving nicotine treatment (GN, gene name)

    AccessionDescriptionCorrelation (r)p Value
    sp|O70174|ACHA4_MOUSENeuronal acetylcholine receptor subunit α4 OS = Mus musculus GN = Chrna4 PE = 2 SV = 20.97<0.0009
    sp|Q2MKA5|ACHA5_MOUSENeuronal acetylcholine receptor subunit α5 OS = Mus musculus GN = Chrna5 PE = 2 SV = 10.91<0.0009
    sp|Q9ERK7|ACHB2_MOUSENeuronal acetylcholine receptor subunit β2 OS = Mus musculus GN = Chrnb2 PE = 2 SV = 11<0.0009
    sp|Q6PIC6|AT1A3_MOUSESodium/potassium-transporting ATPase subunit α3 OS = Mus musculus GN = Atp1a3 PE = 1 SV = 10.550.042
    sp|Q62277|SYPH_MOUSESynaptophysin OS = Mus musculus GN = Syp PE = 1 SV = 20.590.026
    • Similar to the results from human cortex samples, presynaptic elements related to vesicle fusion (synaptophysin) and neuronal excitability (ATP1A3) are significantly correlated with nAChR levels.

    • View popup
    Table 6.

    List of proteins identified in three independent proteomic studies: human and mouse cortex (current study) and whole mouse brain (McClure-Begley et al., 2013) (GN, gene name)

    AccessionDescriptionNo. of experiments (found/total)
    ACHA4Neuronal acetylcholine receptor subunit α4 GN = Chrna40/411
    ACHB2Neuronal acetylcholine receptor subunit β2 GN = Chrnb20/411
    ADT1ADP/ATP translocase 1 GN = Slc25a4195/411
    ADT2ADP/ATP translocase 2 GN = Slc25a5223/411
    AT1A3Sodium/potassium-transporting ATPase subunit α3 GN = Atp1a3101/411
    AT1B1Sodium/potassium-transporting ATPase subunit β1 GN = Atp1b11/411
    ATPAATP synthase subunit α, mito GN = Atp5a1210/411
    ATPBATP synthase subunit β, mito GN = Atp5b211/411
    CALMCalmodulin GN = Calm1133/411
    EAA2Excitatory amino acid transporter 2 GN = Slc1a22/411
    G3PGlyceraldehyde-3-phosphate dehydrogenase GN = GAPDH248/411
    GBB1Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit β1 GN = Gnb159/411
    GFAPGlial fibrillary acidic protein GN = GFAP73/411
    GNAOGuanine nucleotide-binding protein G(o) subunit α GN = Gnao142/411
    KCC2ACalcium/calmodulin-dependent protein kinase type II subunit α GN = CaMKIIa7/411
    KCC2BCalcium/calmodulin-dependent protein kinase type II subunit β GN = CaMKIIb7/411
    MBPMyelin basic protein GN = Mbp0/411
    MPCPPhosphate carrier protein, mito GN = Slc25a3130/411
    MYH10Myosin-10 GN = Myh10166/411
    MYL6Myosin light polypeptide 6 GN = Myl6190/411
    NDUS3NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mito GN = Ndufs319/411
    NDUV2NADH dehydrogenase [ubiquinone] flavoprotein 2, mito GN = Ndufv23/411
    NFLNeurofilament light polypeptide GN = NeflNot in database
    NFMNeurofilament medium polypeptide GN = Nefm85/411
    ODO2Dihydrolipoyllysine-res succinyltransferase 2-oxoglutarate dehydrogenase complex, mito GN = Dlst57/411
    SNP25Synaptosomal-associated protein 25 GN = Snap250/411
    SPTB2Spectrin β chain, nonerythrocytic 1 GN = Sptbn1143/411
    SPTN1Spectrin α chain, nonerythrocytic 1 GN = Sptan1161/411
    STX1BSyntaxin-1B GN = Stx1b0/411
    SYT1Synaptotagmin-1 GN = Syt10/411
    TBA4ATubulin α4A chain GN = Tuba4a377/411
    TBB2ATubulin β2A chain GN = Tubb2a372/411
    TBB3Tubulin β3 chain GN = Tubb3Not in database
    TBB4ATubulin β4A chain GN = Tubb4a366/411
    TBB4BTubulin β4B chain GN = Tubb4b376/411
    TBB5Tubulin β5 chain GN = Tubb5Not in database
    VATAV-type proton ATPase catalytic subunit A GN = Atp6v1a62/411
    • Numbers in the right hand column represent the number of times each protein has been identified in control studies designed to evaluate background contaminants (Mellacheruvu et al., 2013).

    • View popup
    Table 7.

    β2*-nAChR-associated proteins with abundances that are significantly affected by nicotine use and/or mood disorder status in human temporal cortex

    AccessionDescriptionSignificant effectFp Value
    1433Z_HUMAN14-3-3 protein zeta/deltaMD x NicotineF(1,17) = 4.9430.043
    ACHA4_HUMANNeuronal acetylcholine receptor subunit α4NicotineF(1,17) = 16.596<0.0009
    ACHB2_HUMANNeuronal acetylcholine receptor subunit β2NicotineF(1,17) = 12.881<0.0009
    AT1A1_HUMANSodium/potassium-transporting ATPase subunit α1NicotineF(1,17) = 7.4600.016
    AT1A2_HUMANSodium/potassium-transporting ATPase subunit α2Nicotine, MD × nicotineF(1,17) = 5.749; F(1,17) = 4.7400.031; 0.047
    AT1A3_HUMANSodium/potassium-transporting ATPase subunit α3NicotineF(1,17) = 5.8200.03
    AT1B1_HUMANSodium/potassium-transporting ATPase subunit β1NicotineF(1,17) = 7.5370.016
    AT2B2_HUMANPlasma membrane calcium-transporting ATPase 2NicotineF(1,17) = 13.2460.003
    GNAO_HUMANGuanine nucleotide-binding protein G(o) subunit αNicotineF(1,17) = 5.0770.041
    MYPR_HUMANMyelin proteolipid proteinNicotineF(1,17) = 8.7790.01
    S10A7_HUMANProtein S100-A7NicotineF(1,17) = 5.8500.03
    SNP25_HUMANSynaptosomal-associated protein 25NicotineF(1,17) = 11.9900.004
    STX1A_HUMANSyntaxin-1ANicotineF(1,17) = 11.5060.004
    STX1B_HUMANSyntaxin-1BNicotineF(1,17) = 11.7920.004
    VPP1_HUMANV-type proton ATPase 116 kDa subunit a isoform 1NicotineF(1,17) = 5.9460.029
    • Nicotine use has the largest statistical effect observed in terms of its impact on β2*-nAChR expression and the abundance of associated proteins. Only two proteins (14-3-3ζ and ATP1A2) show a significant interaction between nicotine use and mood disorder.

    • View popup
    Table 8.

    β2*-nAChR-associated proteins that show a significant effect of nicotine use on their “per-β2” abundance from human temporal cortex

    AccessionDescriptionSignificant effectFp Value
    GBB1_HUMANGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit β1NicotineF(1,17) = 10.0850.007
    RO52_HUMANE3 ubiquitin-protein ligase TRIM21NicotineF(1,17) = 5.6760.031
    STX1A_HUMANSyntaxin-1ANicotineF(1,17) = 5.3750.036
    TPM4_HUMANTropomyosin α4-chainNicotineF(1,17) = 5.9110.029
    VAOD1_HUMANV-type proton ATPase subunit d 1NicotineF(1,17) = 6.7000.021
    • These proteins have abundance indices that correlate significantly with levels of β2-nAChR, but the effect of nicotine is apparent only when protein content is normalized to total β2-nAChR levels, suggesting that their expression does not track linearly with increases in nAChR due to nicotine-induced upregulation and likely represent limiting interactions.

Back to top

In this issue

eneuro: 3 (4)
eNeuro
Vol. 3, Issue 4
July/August 2016
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex
Tristan D. McClure-Begley, Irina Esterlis, Kathryn L. Stone, TuKiet T. Lam, Sharon R. Grady, Christopher M. Colangelo, Jon M. Lindstrom, Michael J. Marks, Marina R. Picciotto
eNeuro 3 August 2016, 3 (4) ENEURO.0166-16.2016; DOI: 10.1523/ENEURO.0166-16.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex
Tristan D. McClure-Begley, Irina Esterlis, Kathryn L. Stone, TuKiet T. Lam, Sharon R. Grady, Christopher M. Colangelo, Jon M. Lindstrom, Michael J. Marks, Marina R. Picciotto
eNeuro 3 August 2016, 3 (4) ENEURO.0166-16.2016; DOI: 10.1523/ENEURO.0166-16.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • addiction
  • cortex
  • depression
  • nicotine
  • nicotinic acetylcholine receptors
  • proteomics

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Disorders of the Nervous System

  • Alpha-2 Adrenergic Agonists Reduce Heavy Alcohol Drinking and Improve Cognitive Performance in Mice
  • The E-protein Daughterless regulates olfactory learning of adult Drosophila melanogaster
  • Lasting Increases in Neuronal Activity and Serotonergic Receptor Expression Following Gestational Chlorpyrifos Exposure
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.